Activation of T cells by the ragged tail of MHC class II-presented peptides of the measles virus fusion protein

International Immunology

Volumn 8, Issue 4, 1996, Pages 445-456

  Muller, Claude P ^a,b   Ammerlaan, Wim ^a   Fleckenstein, Burkhard ^c,d   Krauss, Steffen ^a,b   Kalbacher, Hubert ^d   Schneider, Francois ^a   Jung, Günther ^c,d   Wiesmüller, Karl Heinz ^c,d  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Antigen processing; DR1; Epitope; Peptide

Indexed keywords

EPITOPE; HYBRID PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CELL CLONE; CELL INTERACTION; CELL PROLIFERATION; CONTROLLED STUDY; HAPLOTYPE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; LYMPHOCYTE; MEASLES VIRUS; MEMORY CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; T LYMPHOCYTE ACTIVATION;

ADULT; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BINDING SITES; BINDING, COMPETITIVE; CELLS, CULTURED; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR1 ANTIGEN; HUMANS; LYMPHOCYTE ACTIVATION; MEASLES VIRUS; PEPTIDES; T-LYMPHOCYTES; VIRAL FUSION PROTEINS;

EID: 0029926370     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.4.445     Document Type: Article

References (62)

1. - cytotoxic T cell clones J Immunol. 142:2847
2. + class I MHC-restricted CTL J. Immunol. 144 2394.
3. van Binnendijk, R. S., Van Baalen, C. A., Poelen, M C., de Vries, P., Boes, J., Cerundolo, V., Osterhaus, A. D. and Uytdehaag, F. G. 1992 Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognition. J. Exp Med. 176.119
4. van Binnendijk, R. S , Versteeg van Oosten, J P , Poelen, M C , Brugghe, H F., Hoogerhout, P , Osterhaus, A. D. and Uytdehaag F. G. 1993. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein. J. Virol. 67.2276.
5. Makela, M. J., Marusyk, R. G., Norrby, E , Tyrrell, D L. and Salmi, A. A. 1989. Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccination. Vaccine 7:541
6. Albrecht, P., Ennis, F A , Saltzman, E J. and Krugman, S 1977. Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. J. Pediatr 91:715.
7. Black, F L 1989 Measles active and passive immunity in a worldwide perspective Progr Med. Virol 36 1.
8. Giraudon, P. and Wild, T F. 1985 Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity Virology 144.46
9. Sato, T A , Kohama, T and Sugiura, A 1989. Protective role of human antibody to the fusion protein of measles virus. Microbiol Immunol 33.601
10. Malvotsin, E and Wild, F 1990. Contribution of measles virus fusion protein in protective immunity anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge J Virol 64:5160
11. Merz, D C , Scheid, A and Choppin, P W 1980. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection J Exp Med. 151 275
12. Norrby, E , Enders-Ruckle, G and ter Meulen, V 1975 Differences in the appearances of antibodies to structural components of measles after immunization with inactivated and live virus J Infect Dis 132 262
13. Partidos, C D. and Steward, M W 1990 Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans J. Gen Virol 71.2099
14. Greenstein, J I. and McFarland H F 1983. Response of human lymphocytes to measles virus after natural infection Infect Immun. 40 198
15. Ilonen, J , Reunamen, M , Herva, E , Ziola, B and Salmi, A. 1980 Stimulation of lymphocytes from subacute sclerosing panencephalitis patients by defined measles virus antigens Cell. Immunol 51.201.
16. Parker, D C 1993 T cell-dependent B cell activation. Annu Rev. Immunol. 11 331
17. Sercarz, E. E., Lehmann, P. V., Ametani, A., Benichou, G , Miller, A and Moudgil, K 1993. Dominance and crypticity of T cell antigenic determinants Annu. Rev. Immunol. 11:729.
18. Wiertz, E. J., van Gaans van den Brink, J A , Gausepohl, H , Prochnicka Chalufour, A., Hoogerhout, P and Poolman, J. T. 1992. Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis. J Exp. Med. 176.79.
19. Levely, M E , Bannow, C A , Smith, C W. and Nicholas, J. A. 1991. Immunodominant T-cell epitope on the F protein of respiratory syncytial virus recognized by human lymphocytes J. Virol 65.3789
20. Engelhard, V H 1994. Structure of peptides associated with MHC class I molecules Curr. Opin. Immunol 6:13.
21. Rammensee, H. G., Friede, T. and Stevanovic, S 1995 MHC ligands and peptide motifs: first listing. Immunogenetics 41 178
22. Rudensky, A Y , Preston Hurlburt, P , Hong, S. C , Barlow, A. and Janeway, C A. J. 1991 Sequence analysis of peptides bound to MHC class II molecules [see comments]. Nature 353:622.
23. Muller, C.P., Beauverger, P , Schneider, F., Jung, G. and Brons, N H.C 1995. Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus. J Gen Virol. 76 1371
24. Vialard, J., Lalumiere, M., Vernet, T., Briedis, D., Alkhatib, G., Henning, D., Levin, D. and Richardson, C. 1990. Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta-galactosidase gene. J Virol. 64:37.
25. Richardson, C , Hull, D., Greer, P , Hasel, K., Berkovich, A., Englund, G., Bellini, W., Rima, B and Lazzarini, R. 1986. The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain) a comparison of fusion proteins from several different paramyxoviruses Virology 155:508.
26. Buckland, R , Gerald, C., Barker, R. and Wild, T F 1987. Fusion glycoprotein of measles virus, nucleotide sequence of the gene and comparison with other paramyxoviruses J. Gen. Virol 68 1695
27. Wiesmuller, K H , Spahn, G., Handtmann, D , Schneider, F., Jung, G and Muller C P 1992 Heterogeneity of linear B cell epitopes of the measles virus fusion protein reacting with late convalescent sera. J Gen. Virol. 73:2211.
28. Kropshofer, H , Bohlinger, I , Max, H and Kalbacher, H. 1991. Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via tryptophan pockets. Biochemistry 30 9177
29. Kropshofer, H , Max, H , Muller, C A , Hesse, F , Stevanovic, S., Jung G. and Kalbacher, H. 1992. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif J Exp Med 175 1799
30. Muller, C P , Bunder, R , Mayser, H , Ammon, S , Weinmann, M , Brons, N. H. C., Schneider, F , Jung, G and Wiesmuller, K. H. 1995. Intramolecular immunodominance and intermolecular selection of H2d-restricted peptides define the same immunodominant region of the measles virus fusion protein. Mol Immunol. 32:37
31. Borrow, P and Oldstone M B A. 1995 Measles virus-mononuclear cell interactions In ter Meulen, V and Billeter, M. A , eds, Measles Virus, p 85 Springer-Verlag, Berlin
32. Gerlier, D , Trescol Biemont, M C , Varior Krishnan, G , Naniche, D , Fugier Vivier, I and Rabourdin Combe, C 1994 Efficient major histocompatibtlity complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells. J. Exp. Med 179.353.
33. Rotzschke, O and Falk, K 1994 Origin, structure and motifs of naturally processed MHC class II ligands Curr. Opin Immunol. 6 45
34. Hammer J , Takacs, B. and Sinigaglia, F. 1992 Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med 176:1007
35. Falk, K., Rotzschke, O , Stevanovic, S , Jung, G and Rammensee, H G 1994 Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39:230
36. Hammer, J , Valsasnini, P , Tolba, K., Bolin, D , Higelin, J., Takacs, B. and Sinigaglia, F. 1993 Promiscuous and allele-specific anchors in HLA-DR-binding peptides Cell 74, 197.
37. Chicz, R M., Urban, R. G , Lane, W. S., Gorga, J. C., Stern, L J., Vignali, D A and Strominger J L 1992 Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358 764.
38. Hammer, J , Belunis, C , Bolin, D., Papadopoulos, J , Walsky, R , Higelin, J , Danho, W and Nagy, Z A. 1994 High affinity binding of short peptides to major histocompatibility complex molecules by anchor combinations Proc. Natl Acad. Sci. USA 91:4456
39. Hill, C. M , Hayball, J D , Allison, A. A. and Rothbard, J B 1991 Conformational and structural characteristics of peptides binding to HLA-DR molecules. J Immunol. 147 189
40. Jorgensen, J L., Reay, P A., Ehrich, E W and Davis, M M 1992 Molecular components of T-cell recognition. Annu Rev. Immunol 10:835.
41. Jardetzky, T. S., Gorga, J. C., Busch, R., Rothbard, J., Strominger, J L and Wiley, D. C. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding EMBO J 9:1797.
42. Ebner, C., Schenk, S , Najafian, N , Siemann, U , Steiner, R , Fischer, G. W , Hoffmann, K., Szepfalusi, Z., Scheiner, O. and Kraft, D. 1995. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J. Immunol 154 1932
43. Coelingh, K V and Tierney, E. L 1989 Identification of amino acids recognized by syncytium-inhibiting and neutralizing monoclonal antibodies to the human parainfluenza type 3 virus fusion protein J Virol 63.3755
44. Toyoda, T , Gotoh, B , Sakaguchi, T , Kida, H and Nagai, Y. 1988 Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization J Virol. 62:4427.
45. Lobigs, M , Dalgarno, L , Schlesinger, J J and Weir, R C 1987 Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain) Virology 161 474
46. Burns, J M , Jr , Majarian, W R., Young, J F. Daly, T. M and Long. C. A 1989 A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii J. Immunol. 143 2670.
47. Puy, H., Fuentes, V. Eb. F and Orfila J 1989 [Biochemical characteristics and antigenic structures of Chlamydia]. Ann. Biol Clin. Paris 47:485
48. Kekomaki, R., Dawson, B McFarland, J and Kunicki, T J 1991 Localization of human platelet autoantigens to the cysteine-rich region of glycoprotein IIIa J Clin Invest 88:847
49. Richardson C D and Choppin, P W 1983 Ogopeptides that specifically inhibit membrane fusion by paramyxoviruses, studies on the site of action Virology 131 518
50. Stern, L J., Brown, J H , Jardetzky, T S , Gorga, J C , Urban, R G Strominger, J L and Wiley, D. C 1994 Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide Nature 368:215
51. Sinigaglia, F. and Hammer, J. 1994 Defining rules for the peptide - MHC class II interaction. Curr. Opin. Immunol. 6.52.
52. O'sullivan, D , Arrhenius, T , Sidney, J., Del Guercio, M F , Albertson M., Wall, M., Oseroff, C , Southwood, S., Colon S M , Gaeta, F C., et al 1991 On the interaction of promiscuous antigenic peptides with different DR alleles Identification of common structural motifs J Immunol 147 2663.
53. Madden, D R 1995 The three-dimensional structure of peptide-MHC complexes Annu Rev Immunol 13:587
54. Rudensky, A Y , Preston Hurlburt, P., al Ramadi, B K , Rothbard, J. and Janeway, C. A , Jr 1992. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature 359 429.
55. Nelson, C A., Roof, R. W., McCourt, D. W and Unanue, E. R. 1992 Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak. Proc Natl Acad. Sci. USA 89:7380.
56. Schwartz, R H 1985. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex Annu. Rev Immunol 3 237
57. Nelson, C A , Petzold, S J and Unanue, E. R. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell [see comments]. Nature 371:250
58. Vignali, D. A. and Strominger, J L. 1994. Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor. J. Exp. Med. 179.1945.
59. Lanzavecchia A. 1990 Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu Rev Immunol 8.773.
60. Michalek, M T , Benacerraf, B and Rock, K. L 1989. Two genetically identical antigen-presenting cell clones display heterogeneity in antigen processing Proc Natl Acad. Sci USA 86 3316
61. Jacobson, S , Sekaly, R. P , Jacobson, C L., McFarland, H F and Long, E. O 1989 HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells J. Virol. 63 1756.
62. Sekaly, R P , Jacobson, S , Richert, J R , Tonnelle, C , McFarland, H F and Long, E O 1988 Antigen presentation to HLA class II-restricted measles virus-specific T-cell clones can occur in the absence of the invariant chain Proc Natl Acad Sci USA 85:1209